Immunopathology of multiple sclerosis

Human gut microbiome viewed across age and geography

Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815

From inflammation to sickness and depression: when the immune system subjugates the brain

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395

Integrative analysis of 111 reference human epigenomes

Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368

Multiple sclerosis

Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,699

Structural and functional features of central nervous system lymphatic vessels

Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413

Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336

T cell exhaustion

Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M., Ferguson, P., Whitesell, L., Kelly, T., Saulsbury, F., Chance, P., & Ochs, H. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,576

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439

Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors

Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339

Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis

Schweitzer, F., Laurent, S. A., Fink, G. R., Barnett, M. H., Hartung, H., & Warnke, C. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09690-6 · Cited by 40

Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal Models

Mockus, T. E., Munie, A. N., Atkinson, J., & Segal, B. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000797 · Cited by 38

The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis

Mandolesi, G., Rizzo, F. R., Balletta, S., Bassi, M. S., Gilio, L., Guadalupi, L., Nencini, M., Moscatelli, A., Ryan, C. P., Licursi, V., et al. (2021) · Cells · doi:10.3390/cells10020330 · Cited by 38

Carnosine quenches the reactive carbonyl acrolein in the central nervous system and attenuates autoimmune neuroinflammation

Spaas, J., Franssen, W. M. A., Keytsman, C., Blancquaert, L., Vanmierlo, T., Bogie, J. F. J., Broux, B., Hellings, N., van Horssen, J., Posa, D. K., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02306-9 · Cited by 38

Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway

Li, G., Yamasaki, R., Fang, M., Masaki, K., Ochi, H., Matsushita, T., & Kira, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20390-5 · Cited by 40

Post‐mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms

Fransen, N. L., Crusius, J. B. A., Smolders, J., Mizee, M. R., van Eden, C. G., Luchetti, S., Remmerswaal, E. B. M., Hamann, J., Mason, M. R. J., & Huitinga, I. (2020) · Brain Pathology · doi:10.1111/bpa.12760 · Cited by 37

MIF contribution to progressive brain diseases

Matejuk, A., Benedek, G., Bucala, R., Matejuk, S., Offner, H., & Vandenbark, A. A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02993-6 · Cited by 40

Nogo-A Antibodies for Progressive Multiple Sclerosis

Ineichen, B. V., Plattner, P. S., Good, N., Martinꝉ, R., Linnebank, M., & Schwab, M. E. (2017) · CNS Drugs · doi:10.1007/s40263-017-0407-2 · Cited by 37

Innate lymphoid cells in autoimmunity and chronic inflammatory diseases

Xiong, T., & Turner, J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0670-4 · Cited by 37

Intrathecal delivery of human ESC-derived mesenchymal stem cell spheres promotes recovery of a primate multiple sclerosis model

Yan, L., Jiang, B., Niu, Y., Wang, H., Li, E., Yan, Y., Sun, H., Duan, Y., Chang, S., Chen, G., et al. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0091-0 · Cited by 37

IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression

Gharibi, T., Hosseini, A., Marofi, F., Oraei, M., Jahandideh, S., Abdollahpour‐Alitappeh, M., Hashemi, V., Motallebnezhad, M., Babaloo, Z., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.09.003 · Cited by 38

CNS-localized myeloid cells capture living invading T cells during neuroinflammation

Wasser, B., Luchtman, D. W., Löffel, J. T., Robohm, K., Birkner, K., Stroh, A., Vogelaar, C. F., Zipp, F., & Bittner, S. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190812 · Cited by 38

Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis

Lipphardt, M., Wallbach, M., & Koziolek, M. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051597 · Cited by 38

Multifaceted Involvement of Microglia in Gray Matter Pathology in Multiple Sclerosis

Tsouki, F., & Williams, A. (2021) · Stem Cells · doi:10.1002/stem.3374 · Cited by 39

Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health

Bhatia, N. Y., Jalgaonkar, M. P., Hargude, A. B., Sherje, A. P., Oza, M. J., & Doshi, G. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220822172039 · Cited by 38

PET imaging in multiple sclerosis

Faria, D. D. P., Copray, S. C. V. M., Buchpiguel, C. A., Dierckx, R., & de Vries, E. F. J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9544-2 · Cited by 40

Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases

Zhen, M., Xu, Y. M., Wang, C., & Bai, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202409319 · Cited by 36

Scaling up spatial transcriptomics for large-sized tissues: uncovering cellular-level tissue architecture beyond conventional platforms with iSCALE

Schroeder, A. R., Loth, M., Luo, C., Yao, S., Yan, H., Zhang, D., Piya, S., Plowey, E. D., Hu, W., Clemenceau, J. R. V., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02770-8 · Cited by 37

Pericytes modulate myelination in the central nervous system

de Azevedo, P. O., Sena, I. F. G., Andreotti, J. P., Tavares, J. C., Alves-Filho, J. C., Cunha, T. M., Cunha, F. Q., Mintz, A., & Birbrair, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26348 · Cited by 36

Cognitive function predicts work disability among multiple sclerosis patients

Kavaliūnas, A., Tinghög, P., Friberg, E., Olsson, T. P., Alexanderson, K. A. E., Hillert, J. A., & Karrenbauer, V. D. (2019) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217318822134 · Cited by 36

Ongoing Research on the Role of Gintonin in the Management of Neurodegenerative Disorders

Ikram, M. A., Ullah, R., Khan, A., & Kim, M. O. (2020) · Cells · doi:10.3390/cells9061464 · Cited by 36

Distinct Functional Connectivity Signatures of Impaired Social Cognition in Multiple Sclerosis

Golde, S., Heine, J., Pöttgen, J., Mantwill, M., Lau, S., Wingenfeld, K., Otte, C., Penner, I., Engel, A. K., Heesen, C., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00507 · Cited by 36

Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer

Baart, V. M., Houvast, R. D., de Geus‐Oei, L., Quax, P. H. A., Kuppen, P. J. K., Vahrmeijer, A. L., & Sier, C. F. M. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00673-7 · Cited by 36

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers

Filippo, M. D., Gaetani, L., Salvadori, N., Chipi, E., Gentili, L., Borrelli, A., & Parnetti, L. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.286949 · Cited by 37

Contributions of T cells in multiple sclerosis: what do we currently know?

Arneth, B. M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10275-x · Cited by 36

Gintonin mitigates experimental autoimmune encephalomyelitis by stabilization of Nrf2 signaling via stimulation of lysophosphatidic acid receptors

Choi, J. H., Oh, J., Lee, M. J., Ko, S., Nah, S.-Y., & Cho, I. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.004 · Cited by 36

The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders

Li, Y.-K., Chen, J., & Wang, F. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105122 · Cited by 36

MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis

Vito, F. D., Musella, A., Fresegna, D., Rizzo, F. R., Gentile, A., Bassi, M. S., Gilio, L., Buttari, F., Procaccini, C., Colamatteo, A., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12765 · Cited by 38

Pomegranate (Punica granatum L.) Attenuates Neuroinflammation Involved in Neurodegenerative Diseases

Alami, M., Benchagra, L., Boulbaroud, S., Ramchoun, M., Khalil, A., Fülöp, T., & Berrougui, H. (2022) · Foods · doi:10.3390/foods11172570 · Cited by 38

Targeted Diet Modification Reduces Multiple Sclerosis–like Disease in Adult Marmoset Monkeys from an Outbred Colony

Kap, Y. S., Bus‐Spoor, C., van Driel, N., Dubbelaar, M. L., Grit, C., Kooistra, S. M., Fagrouch, Z. C., Verschoor, E. J., Bauer, J., Eggen, B. J. L., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800822 · Cited by 36

Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis

Straeten, F. A., Zhu, J. K., Börsch, A., Zhang, B., Li, K., Lu, I., Groß, C. C., Heming, M., Li, X., Rubin, R., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02667-9 · Cited by 38

SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options

Yan, M., Sun, Z., Zhang, S., Yang, G., Jiang, X. Y., Wang, G., Li, R., Wang, Q., & Tian, X. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110988 · Cited by 38

piRNA associates with immune diseases

Jiang, M., Hong, X., Gao, Y., Kho, A. T., Tantisira, K. G., & Li, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01724-5 · Cited by 36

Split crRNA Precisely Assisted Cas12a Expansion Strategy for Simultaneous, Discriminative, and Low-Threshold Determination of Two miRNAs Associated with Multiple Sclerosis

Xia, X., Liang, Z., Xu, G., Wei, F., Yang, J., Zhu, X., Zhou, C., Ye, J., Hu, Q., Zhao, Z., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05388 · Cited by 36

Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis

Aghaie, T., Jazayeri, M. H., Avan, A., Anissian, A., & Salari, A. (2019) · IUBMB Life · doi:10.1002/iub.2045 · Cited by 35

A narrative review of psoriasis and multiple sclerosis: links and risks

Silfvast‐Kaiser, A., Homan, K. B., & Mansouri, B. (2019) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s186637 · Cited by 35

Dynamic Balance of Microglia and Astrocytes Involved in the Remyelinating Effect of Ginkgolide B

Yin, J.-J., He, Y., An, J., Miao, Q., Sui, R., Wang, Q., Yu, J., Xiao, B., & Ma, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00572 · Cited by 35

Neonatal hydrocephalus leads to white matter neuroinflammation and injury in the corpus callosum of Ccdc39 hydrocephalic mice

Goulding, D. S., Vogel, R. C., Pandya, C. D., Shula, C., Gensel, J. C., Mangano, F. T., Goto, J., & Miller, B. A. (2020) · Journal of Neurosurgery Pediatrics · doi:10.3171/2019.12.peds19625 · Cited by 35

Rg3-enriched Korean Red Ginseng extract inhibits blood-brain barrier disruption in an animal model of multiple sclerosis by modulating expression of NADPH oxidase 2 and 4

Lee, M. J., Choi, J. H., Oh, J., Lee, Y. H., In, J.-G., Chang, B., Nah, S.-Y., & Cho, I. (2020) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.09.001 · Cited by 36

The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer

Rubio-Ramos, A., Labat‐de‐Hoz, L., Correas, I., & Alonso, M. A. (2021) · Cells · doi:10.3390/cells10051065 · Cited by 35

Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment

Chatzikonstantinou, S., Poulidou, V., Arnaoutoglou, M., Kazis, D. A., Heliopoulos, I., Grigoriadis, N., & Boziki, M. K. (2021) · Cells · doi:10.3390/cells10113217 · Cited by 35

Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis

Rodriguez-Mogeda, C., Rodríguez‐Lorenzo, S., Attia, J. V. D., van Horssen, J., Witte, M. E., & de Vries, H. E. (2022) · Biomolecules · doi:10.3390/biom12060800 · Cited by 36

The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders

Bashir, Y., & Khan, A. U. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1030694 · Cited by 35

Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?

Morandi, E., Tănăsescu, R., Tarlinton, R. E., Constantin‐Teodosiu, D., & Gran, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03092 · Cited by 35

Nutritional Intervention as an Essential Part of Multiple Sclerosis Treatment?

Penesová, A., Dean, Z., Kollár, B., Havranová, A., Imrich, R., Vlček, M., & Rádiková, Ž. (2018) · Physiological Research · doi:10.33549/physiolres.933694 · Cited by 35

The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis

Monaghan, K. L., & Wan, E. C. K. (2020) · Cells · doi:10.3390/cells9030611 · Cited by 35

Oxidative Stress and the Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Pathway in Multiple Sclerosis: Focus on Certain Exogenous and Endogenous Nrf2 Activators and Therapeutic Plasma Exchange Modulation

Tonev, D. G., & Momchilova, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417223 · Cited by 34

Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System

Thomé, R., de Carvalho, A. C., da Costa, T. A., Ishikawa, L. L. W., Fraga‐Silva, T. F. D. C., Sartori, A., de Oliveira, A. L. R., & Verinaud, L. M. C. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12561 · Cited by 34

Interferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory Disease

Kulkarni, A., Ganesan, P., & O’Donnell, L. A. (2016) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s40497 · Cited by 35

The Role of Neuroinflammation in Neurodegenerative Disorders

Suescun, J., Chandra, S., & Schiess, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813832-8.00013-3 · Cited by 34

Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?

Rádiková, Ž., Penesová, A., Vlček, M., Havranová, A., Siváková, M., Šiarnik, P., Žitňanová, I., Imrich, R., Turčáni, P., & Kollár, B. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01221-x · Cited by 34

MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis

Martinez, B., & Peplow, P. V. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.280307 · Cited by 34

Alcohol and multiple sclerosis: an immune system-based review.

Fahim, M., Zadeh, A. R., Shoureshi, P., Ghadimi, K., Cheshmavar, M., Sheikhinia, N., & Afzali, M. (2020) · PubMed Central · Cited by 34

Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination

Pennati, A., Nylen, E. A., Duncan, I. D., & Galipeau, J. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2840-19.2020 · Cited by 34

Gut Microbiota and Disorders of the Central Nervous System

Vuotto, C., Battistini, L., Caltagirone, C., & Borsellino, G. (2020) · The Neuroscientist · doi:10.1177/1073858420918826 · Cited by 37

CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery

Al‐Mazroua, H. A., Nadeem, A., Ansari, M. A., Attia, S. M., Bakheet, S. A., Albekairi, T. H., Ali, N., Alasmari, F. F., Algahtani, M., Alsaad, A. M. S., et al. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.02.017 · Cited by 34

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells

Zveik, O., Fainstein, N., Rechtman, A., Haham, N., Ganz, T., Lavon, I., Brill, L., & Vaknin‐Dembinsky, A. (2022) · Glia · doi:10.1002/glia.24165 · Cited by 35

Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases

Lan, T., Sun, T., Wei, C., Cheng, T., Yang, F., Zhang, J.-N., & Li, Q. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03267-1 · Cited by 35

Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis

Stanisavljević, S., Lukić, J., Momčilović, M. B., Miljković, M., Jevtić, B., Kojić, M., Golić, N., Stojković, M. M., & Miljković, D. M. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0159 · Cited by 34

Knockout of P2Y12 aggravates experimental autoimmune encephalomyelitis in mice via increasing of IL-23 production and Th17 cell differentiation by dendritic cells

Zhang, J., Li, Z., Hu, X., Su, Q., He, C., Liu, J., Ren, H., Qian, M., Liu, J., Cui, S., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.001 · Cited by 34

Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis

Rajasundaram, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00402 · Cited by 37

Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Quinn, J., & Axtell, R. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103233 · Cited by 36

Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis

Musella, A., Gentile, A., Guadalupi, L., Rizzo, F. R., Vito, F. D., Fresegna, D., Bruno, A., Dolcetti, E., Vanni, V., Vitiello, L., et al. (2020) · Cells · doi:10.3390/cells9051290 · Cited by 34

Unique Bioactives from Zombie Fungus (Cordyceps) as Promising Multitargeted Neuroprotective Agents

Sharma, H., Sharma, N., & An, S. S. A. (2023) · Nutrients · doi:10.3390/nu16010102 · Cited by 35

Inflammasome Molecular Insights in Autoimmune Diseases

Neamţu, M., Bild, V., Vasincu, A., Arcan, O. D., Bulea, D., Ababei, D. C., Rusu, R.-N., Macadan, I., Sciucă, A. M., & Neamțu, A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040220 · Cited by 35

Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders

Liu, X., Li, Y., Huang, L., Kuang, Y., Wu, X., Ma, X., Zhao, B., & Lan, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1450704 · Cited by 39

Game of microbes: the battle within – gut microbiota and multiple sclerosis

Turner, T.-A. J., Lehman, P., Ghimire, S., Shahi, S. K., & Mangalam, A. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387794 · Cited by 33

Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis

Bianchini, E., Biasi, S. D., Simone, A. M., Ferraro, D., Sola, P., Cossarizza, A., & Pinti, M. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.01.009 · Cited by 33

Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications

Solouki, S., August, A., & Huang, W. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.008 · Cited by 37

C-type lectin receptors Mcl and Mincle control development of multiple sclerosis–like neuroinflammation

N’diaye, M., Brauner, S., Flytzani, S., Kular, L., Warnecke, A., Adzemovic, M. Z., Piket, E., Min, J.-H., Edwards, W., Mela, F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125857 · Cited by 33

RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation

Chen, J., Martindale, J. L., Abdelmohsen, K., Kumar, G., Fortina, P. M., Gorospe, M., Rostami, A. M., & Yu, S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900769 · Cited by 34

Methylprednisolone alleviates multiple sclerosis by expanding myeloid‐derived suppressor cells via glucocorticoid receptor β and S100A8/9 up‐regulation

Wang, Z., Zheng, G., Li, G., Wang, M., Ma, Z., Li, H., Wang, X., & Yi, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15928 · Cited by 33

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis

Dziedzic, A., Saluk, J., Miller, E. D., Niemcewicz, M., & Bijak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041804 · Cited by 33

In Vivo Induction of Regulatory T Cells Via CTLA‐4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse

Kim, G., Kim, W., Lim, S., Lee, H., Koo, J., Nam, K.-H., Kim, S., Park, S., & Choi, J. (2021) · Advanced Science · doi:10.1002/advs.202004973 · Cited by 33

Linking immune-mediated damage to neurodegeneration in multiple sclerosis: could network-based MRI help?

Groppa, S., González‐Escamilla, G., Eshaghi, A., Meuth, S. G., & Ciccarelli, O. (2021) · Brain Communications · doi:10.1093/braincomms/fcab237 · Cited by 34

Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS Inflammation

Linnerbauer, M., Lößlein, L., Farrenkopf, D., Vandrey, O., Tsaktanis, T., Naumann, U., & Rothhammer, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.800128 · Cited by 33

Laminin as a Biomarker of Blood–Brain Barrier Disruption under Neuroinflammation: A Systematic Review

Zapata-Acevedo, J. F., Perez, V. G., Cabezas-Pérez, R., Losada-Barragán, M., Vargas-Sánchez, K., & González-Reyes, R. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126788 · Cited by 36

Synapse Dysfunctions in Multiple Sclerosis

Schwarz, K., & Schmitz, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021639 · Cited by 36

Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors

Fujisawa, T. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.10.004 · Cited by 33

CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis

Beliën, J., Swinnen, S., D’hondt, R., Verdú de Juan, L., Dedoncker, N., Matthys, P., Bauer, J., Vens, C., Moylett, S., & Dubois, B. (2024) · Nature Communications · doi:10.1038/s41467-024-49312-y · Cited by 32

CD4+HLA-G+ regulatory T cells: Molecular signature and pathophysiological relevance

Pankratz, S., Ruck, T., Meuth, S. G., & Wiendl, H. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.01.016 · Cited by 32

Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates

Stimmer, L., Fovet, C.-M., & Serguera, C. (2017) · Veterinary Pathology · doi:10.1177/0300985817712794 · Cited by 32

Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells

Sharma, M., Arbabzada, N., & Flood, P. M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.017 · Cited by 33

Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis

Zahoor, I., & Giri, S. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08796-4 · Cited by 37

An evaluation on potential anti-inflammatory effects of β-lapachone

Mokarizadeh, N., Karimi, P., Kazemzadeh, H., Maroufi, N. F., Sadigh‐Eteghad, S., Nikanfar, S., & Rashtchizadeh, N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106810 · Cited by 32

Brain energy metabolism and multiple sclerosis: progress and prospects

Park, S. J., & Choi, J. W. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01278-3 · Cited by 32

Revealing vascular abnormalities and measuring small vessel density in multiple sclerosis lesions using USPIO

Buch, S., Subramanian, K., Jella, P. K., Chen, Y., Wu, Z., Shah, K., Bernitsas, E., Ge, Y., & Haacke, E. M. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102525 · Cited by 33

A novel long intergenic non-coding RNA, Nostrill, regulates iNOS gene transcription and neurotoxicity in microglia

Mathy, N. W., Burleigh, O., Kochvar, A. P., Whiteford, E. R., Behrens, M., Marta, P., Tian, C., Gong, A., Drescher, K. M., Steyger, P. S., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02051-5 · Cited by 34

Heat Exposure and Multiple Sclerosis—A Regional and Temporal Analysis

Chacko, G., Patel, S., Galor, A., & Kumar, N. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115962 · Cited by 32

Specific hypomethylation programs underpin B cell activation in early multiple sclerosis

Ma, Q., Caillier, S. J., Muzic, S. I., Wilson, M. R., Henry, R. G., Cree, B., Hauser, S. L., Didonna, A., Oksenberg, J. R., Alexander, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111920118 · Cited by 32

Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective

Archie, S. R., Sharma, S., Burks, E., & Abbruscato, T. J. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.02.002 · Cited by 33

Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis

Lee, C., & Chan, K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010120 · Cited by 32

A potential impact of Helicobacter pylori -related galectin-3 in neurodegeneration

Boziki, M. K., Pοlyzos, S. A., Deretzi, G., Kazakos, E. I., Katsinelos, P., Doulberis, M., Kotronis, G., Giartza‐Taxidou, E., Laskaridis, L., Tzivras, D., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.003 · Cited by 32

Akt-1 and Akt-2 Differentially Regulate the Development of Experimental Autoimmune Encephalomyelitis by Controlling Proliferation of Thymus-Derived Regulatory T Cells

Ouyang, S., Zeng, Q., Tang, N., Guo, H., Tang, R., Yin, W., Wang, A., Tang, H., Zhou, J., Xie, H., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1701204 · Cited by 32

‘Prototypical’ proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting

Musella, A., Fresegna, D., Rizzo, F. R., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bruno, A., Dolcetti, E., Buttari, F., et al. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1709823 · Cited by 33

Advanced in vitro models: Microglia in action

Cakir, B., Kiral, F. R., & Park, I.-H. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.004 · Cited by 32

Human Umbilical Cord–Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study

Jamali, F., Aldughmi, M., Atiani, S., Al‐Radaideh, A., Dahbour, S. S., Alhattab, D. M., Khwaireh, H., Arafat, S., Jaghbeer, J. A., Rahmeh, R., et al. (2024) · Cell Transplantation · doi:10.1177/09636897241233045 · Cited by 32

Biological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system

Almanghadim, H. G., Karimi, B., Valizadeh, S., & Ghaedi, K. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.09.001 · Cited by 32

NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms

Webb, L., Miranda, J. N., Amici, S. A., Sengupta, S., Nagy, G., & Guerau‐de‐Arellano, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00524 · Cited by 31

Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis

Nasi, M., Bianchini, E., Biasi, S. D., Gibellini, L., Neroni, A., Mattioli, M., Pinti, M., Iannone, A., Mattioli, A. V., Simone, A. M., et al. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577107 · Cited by 31

Update on immunopathogenesis and immunotherapy in multiple sclerosis

Hemmer, B., & Selter (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s31813 · Cited by 33

Pathophysiology and Treatment of Multiple Sclerosis: A Review

Dayinta, C. P. T. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10572077

The Immune Response in Multiple Sclerosis

Murúa, S. R., Farez, M., & Quintana, F. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052920-040318 · Cited by 378

Immunologic Aspects of Multiple Sclerosis

Boppana, S., Huang, H., Ito, K., & Dhib-Jalbut, S. S. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20249 · Cited by 40

Immunopathogenesis and immunotherapy of multiple sclerosis

Hemmer, B., Nessler, S., Zhou, D., Kieseier, B. C., & Hartung, H. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0154 · Cited by 259